BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29739756)

  • 21. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
    Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
    Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
    Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
    Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α-2b.
    Chakraborty K; Bose A; Goswami KK; Mukherjee KK; Goswami S; Ghosh D; Chakraborty T; Sarkar K; Pal S; Bhowmick A; Biswas J; Baral R
    Hum Immunol; 2012 Jan; 73(1):38-47. PubMed ID: 22085486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.
    Musrap N; Karagiannis GS; Saraon P; Batruch I; Smith C; Diamandis EP
    J Proteomics; 2014 May; 103():204-15. PubMed ID: 24726482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
    Pascual-Antón L; Cardeñes B; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Cabañas C; Sandoval P
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model.
    Price JC; Azizi E; Naiche LA; Parvani JG; Shukla P; Kim S; Slack-Davis JK; Pe'er D; Kitajewski JK
    PLoS One; 2020; 15(6):e0233962. PubMed ID: 32525899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.
    Estermann M; Huang YL; Septiadi D; Ritz D; Liang CY; Jacob F; Drasler B; Petri-Fink A; Heinzelmann-Schwarz V; Rothen-Rutishauser B
    PLoS One; 2020; 15(12):e0241500. PubMed ID: 33270665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
    Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
    Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
    Parashar D; Nair B; Geethadevi A; George J; Nair A; Tsaih SW; Kadamberi IP; Gopinadhan Nair GK; Lu Y; Ramchandran R; Uyar DS; Rader JS; Ram PT; Mills GB; Pradeep S; Chaluvally-Raghavan P
    Cancer Res; 2020 Dec; 80(24):5554-5568. PubMed ID: 33087324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.
    Kleinmanns K; Fosse V; Davidson B; de Jalón EG; Tenstad O; Bjørge L; McCormack E
    EBioMedicine; 2020 Jun; 56():102783. PubMed ID: 32454402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium.
    Stadlmann S; Feichtinger H; Mikuz G; Marth C; Zeimet AG; Herold M; Knabbe C; Offner FA
    Int J Gynecol Cancer; 2014 Feb; 24(2):192-200. PubMed ID: 24407573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
    Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
    Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
    Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
    J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.
    Haria D; Trinh BQ; Ko SY; Barengo N; Liu J; Naora H
    Am J Pathol; 2015 Aug; 185(8):2298-308. PubMed ID: 26067154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
    Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
    Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophages Promote Ovarian Cancer-Mesothelial Cell Adhesion by Upregulation of ITGA2 and VEGFC in Mesothelial Cells.
    Cho SK; Lee K; Woo JH; Choi JH
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.
    Kim M; Rooper L; Xie J; Kajdacsy-Balla AA; Barbolina MV
    Mol Cancer Res; 2012 Jan; 10(1):11-24. PubMed ID: 22064656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.
    Loessner D; Rockstroh A; Shokoohmand A; Holzapfel BM; Wagner F; Baldwin J; Boxberg M; Schmalfeldt B; Lengyel E; Clements JA; Hutmacher DW
    Biomaterials; 2019 Jan; 190-191():63-75. PubMed ID: 30396040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.